Carole Ho's Insider Trades & SAST Disclosures
Carole Ho's most recent trade in Denali Therapeutics Inc was a trade of 12,255 Common Stock done at an average price of $20.2 . Disclosure was reported to the exchange on Jan. 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carole Ho.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 06 Jan 2025 | 12,255 | 178,580 (0%) | 0% | 20.2 | 247,796 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.81 per share. | 06 Jan 2025 | 2,907 | 175,673 (0%) | 0% | 20.8 | 60,495 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 162,540 | 162,540 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 54,180 | 190,835 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. | 25 Nov 2024 | 17,845 | 136,655 (0%) | 0% | 0.7 | 12,135 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 17,845 | 107,155 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.41 per share. | 20 Aug 2024 | 14,098 | 124,717 (0%) | 0% | 24.4 | 344,132 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.96 per share. | 20 Aug 2024 | 5,907 | 118,810 (0%) | 0% | 25.0 | 147,439 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.79 per share. | 20 Aug 2024 | 2,453 | 138,815 (0%) | 0% | 23.8 | 58,357 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.89 per share. | 13 Aug 2024 | 2,337 | 141,268 (0%) | 0% | 22.9 | 53,494 | Common Stock |
| Beam Therapeutics Inc | Carole Ho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 23,114 | 23,114 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Carole Ho | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 78,407 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Carole Ho | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 39,515 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Carole Ho | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 24,222 | 0 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Carole Ho | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2024 | 19,619 | 0 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.29 per share. | 13 Feb 2024 | 2,784 | 145,010 (0%) | 0% | 17.3 | 48,135 | Common Stock |
| Denali Therapeutics Inc | Ho Carole | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.79 per share. | 13 Feb 2024 | 1,405 | 143,605 (0%) | 0% | 17.8 | 24,995 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.02 per share. | 10 Jan 2024 | 4,668 | 147,794 (0%) | 0% | 19.0 | 88,785 | Common Stock |
| Denali Therapeutics Inc | Ho Carole | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.43 per share. | 05 Jan 2024 | 9,972 | 198,777 (0%) | 0% | 19.4 | 193,756 | Common Stock |
| Denali Therapeutics Inc | Ho Carole | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 161,160 | 161,160 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 53,720 | 162,434 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.22 per share. | 23 Aug 2023 | 2,522 | 182,809 (0%) | 0% | 23.2 | 58,561 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.60 per share. | 21 Aug 2023 | 2,478 | 185,331 (0%) | 0% | 22.6 | 56,003 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.79 per share. | 14 Aug 2023 | 2,768 | 182,809 (0%) | 0% | 23.8 | 65,851 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.15 per share. | 10 Aug 2023 | 2,857 | 185,577 (0%) | 0% | 24.2 | 68,997 | Common Stock |
| Beam Therapeutics Inc | Carole Ho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,532 | 16,532 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.40 per share. | 15 Feb 2023 | 1,476 | 182,809 (0%) | 0% | 29.4 | 43,394 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.10 per share. | 10 Feb 2023 | 2,548 | 184,285 (0%) | 0% | 30.1 | 76,695 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 29.80 per share. | 10 Feb 2023 | 818 | 179,365 (0%) | 0% | 29.8 | 24,376 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.88 per share. | 08 Feb 2023 | 1,521 | 180,183 (0%) | 0% | 30.9 | 46,968 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.48 per share. | 09 Jan 2023 | 1,459 | 177,454 (0%) | 0% | 28.5 | 41,552 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.44 per share. | 05 Jan 2023 | 2,636 | 180,364 (0%) | 0% | 28.4 | 74,968 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.67 per share. | 05 Jan 2023 | 1,451 | 178,913 (0%) | 0% | 28.7 | 41,600 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 123,360 | 123,360 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 41,120 | 138,967 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 28.69 per share. | 03 Jan 2023 | 2,913 | 175,500 (0%) | 0% | 28.7 | 83,574 | Common Stock |
| Beam Therapeutics Inc | Carole Ho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 10,391 | 10,391 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.98 per share. | 23 Aug 2022 | 2,424 | 170,663 (0%) | 0% | 32.0 | 77,520 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.22 per share. | 19 Aug 2022 | 2,576 | 173,087 (0%) | 0% | 33.2 | 85,575 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 22,500 | 110,597 (0%) | 0% | 0 | Common Stock | |
| Ngm Biopharmaceuticals Inc | Carole Ho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 24,222 | 24,222 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.71 per share. | 11 Feb 2022 | 2,918 | 170,663 (0%) | 0% | 34.7 | 101,284 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.10 per share. | 09 Feb 2022 | 1,423 | 166,112 (0%) | 0% | 37.1 | 52,791 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 44.78 per share. | 05 Jan 2022 | 2,845 | 163,285 (0%) | 0% | 44.8 | 127,399 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 93,000 | 93,000 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 31,000 | 107,316 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.52 per share. | 06 Dec 2021 | 1,476 | 76,316 (0%) | 0% | 42.5 | 62,760 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 48.91 per share. | 23 Aug 2021 | 6,143 | 158,630 (0%) | 0% | 48.9 | 300,454 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 49.31 per share. | 19 Aug 2021 | 1,402 | 165,917 (0%) | 0% | 49.3 | 69,133 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 49.91 per share. | 19 Aug 2021 | 1,144 | 164,773 (0%) | 0% | 49.9 | 57,097 | Common Stock |
| Beam Therapeutics Inc | Carole Ho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 6,877 | 6,877 | - | - | Stock Option (Right to Buy) | |
| Ngm Biopharmaceuticals Inc | Carole Ho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 19,619 | 19,619 | - | - | Stock Option (Right to Buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 54.62 per share. | 29 Mar 2021 | 2,822 | 162,319 (0%) | 0% | 54.6 | 154,126 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 65.73 per share. | 01 Mar 2021 | 2,871 | 168,035 (0%) | 0% | 65.7 | 188,725 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.54 per share. | 01 Mar 2021 | 1,327 | 170,906 (0%) | 0% | 64.5 | 85,646 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 68.01 per share. | 01 Mar 2021 | 1,320 | 165,542 (0%) | 0% | 68.0 | 89,772 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 67.07 per share. | 01 Mar 2021 | 1,173 | 166,862 (0%) | 0% | 67.1 | 78,670 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 68.87 per share. | 01 Mar 2021 | 208 | 165,334 (0%) | 0% | 68.9 | 14,324 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 70.06 per share. | 01 Mar 2021 | 125 | 165,209 (0%) | 0% | 70.1 | 8,758 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 71.26 per share. | 01 Mar 2021 | 68 | 165,141 (0%) | 0% | 71.3 | 4,846 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 70.17 per share. | 11 Feb 2021 | 2,756 | 172,633 (0%) | 0% | 70.2 | 193,377 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 71.48 per share. | 11 Feb 2021 | 400 | 172,233 (0%) | 0% | 71.5 | 28,594 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2021 | 4,250 | 169,391 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2021 | 4,250 | 8,500 | - | - | Restricted Stock Units | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 74.40 per share. | 07 Feb 2021 | 1,006 | 168,385 (0%) | 0% | 74.4 | 74,847 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 75.10 per share. | 07 Feb 2021 | 364 | 168,021 (0%) | 0% | 75.1 | 27,337 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 07 Feb 2021 | 100 | 167,921 (0%) | 0% | 76 | 7,600 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.28 per share. | 08 Oct 2020 | 30,000 | 196,617 (0%) | 0% | 5.3 | 158,400 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2020 | 30,000 | 38,240 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.28 per share. | 08 Oct 2020 | 22,906 | 189,523 (0%) | 0% | 5.3 | 120,944 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.12 per share. | 08 Oct 2020 | 22,906 | 166,617 (0%) | 0% | 40.1 | 918,989 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.51 per share. | 08 Oct 2020 | 19,535 | 166,617 (0%) | 0% | 41.5 | 810,898 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2020 | 13,020 | 44,035 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 40.68 per share. | 08 Oct 2020 | 10,465 | 186,152 (0%) | 0% | 40.7 | 425,716 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2020 | 9,886 | 68,240 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.00 per share. | 10 Sep 2020 | 3,689 | 165,141 (0%) | 0% | 31 | 114,359 | Common Stock |
| Denali Therapeutics Inc | Carole Ho | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| Ngm Biopharmaceuticals Inc | Carole Ho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 39,515 | 39,515 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges